Due Diligence: $ISOL $ISOL.C $LAGBF IMO, why this could be a MONSTER RUNNER!!! Isodiol International Inc. (LAGBF)
\ https://isodiol.com/ Share Structure: OS as of 7/5/2017: 173,251,961
US PPS as of 7/27/17: .245
US MARKET CAP: 42,446,730 Revenue & Profit: June Sales: $1,843,173 CAD
Apr-June 2017 Sales: $4,919,693 CAD
Apr - June 2017 PROFIT: $897,596 CAD
This company is growing quick, but if we just take June's Sales x 12 months we are at: $22,118,076 CAD Yearly Revenue Now remember market cap is only at 42 million US Dollars.
Compared it to Canopy Growth Corporation (TWMJF) which has a market cap of $1.37 CAD billion. Revenue was $14.7 million with big losses for last quarter.
Do I need to say anymore? LATEST NEWS VANCOUVER, British Columbia , July 26, 2017 (GLOBE NEWSWIRE) -- Isodiol
International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) (the “Company” or
“Isodiol”) a global cannabis innovator, specializing in the development of
pharmaceutical and consumer products, announces the operational numbers of its
wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017 . Iso
International LLC recorded unaudited fiscal Q1 profits of $897,596 based on
revenues of $4,919,693 CAD.
Marcos Agramont , CEO of Isodiol , stated, “Demonstrating Q1 profitability is a
major milestone for our company and our investors. The cannabis industry on a
whole will be legitimized by demonstrating successful commercialization and
operating in an environment which promotes the cannabis movement. We have
developed product lines and brands which will generate revenues and
profitability and now we’re positioned to begin exploring additional expansion
opportunities. Vertical integration, expanding product distribution channels and
out-of-state manufacturing and processing are all opportunities we will
aggressively develop and execute.” Isodiol International Inc. Announces Corporate Update
VANCOUVER, July 11, 2017 /CNW/ - IsodiolInternationalInc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the "Company"
or "Isodiol")a globalcannabis innovator specializing in the development of pharmaceuticaland consumer products, today released its unaudited
consolidated sales figures for the month of June 2017. The company recorded sales of $1,843,173 CAD for the thirty-day period ended June 30,
2017. Total quarterly sales were $4,919,693 CAD for the period April 1
st to June 30th, 2017.